ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

ClinicalTrials.gov ID: NCT01877668

Public ClinicalTrials.gov record NCT01877668. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis

Study identification

NCT ID
NCT01877668
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
422 participants

Conditions and interventions

Interventions

  • Adalimumab Drug
  • Placebo Drug
  • Tofacitinib 10 mg BID Drug
  • Tofacitinib 5 mg BID Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 19, 2014
Primary completion
Dec 17, 2015
Completion
Dec 17, 2015
Last update posted
Jul 5, 2017

2014 – 2015

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Rheumatology Associates, PC Birmingham Alabama 35205
Rheumatology Associates of North Alabama, PC Huntsville Alabama 35801
Arizona Arthritis & Rheumatology Associates, P.C. Glendale Arizona 85306
Medvin Clinical Research Covina California 91723
Desert Medical Advances Palm Desert California 92260
Advances In Medicine (X-Rays) Rancho Mirage California 92270
San Diego Arthritis Medical Clinic San Diego California 92108
Millennium Research Ormond Beach Florida 32174
Arthritis Center, Inc. Palm Harbor Florida 34684
Klein & Associates, M.D., P.A. Hagerstown Maryland 21740
Clinical Pharmacology Study Group Worcester Massachusetts 01605
St. Paul Rheumatology, PA Eagan Minnesota 55121
Physician Research Collaboration, LLC Lincoln Nebraska 68516
Dartmouth-Hitchcock Medical Center (DHMC) Lebanon New Hampshire 03756
Paramount Medical Research & Consulting, LLC Middleburg Heights Ohio 44130
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Low Country Rheumatology, PA Charleston South Carolina 29406
Pioneer Research Solutions, Inc. Houston Texas 77008
Drug Shipment/Storage: Huntsman Cancer Hospital at the University of Utah Salt Lake City Utah 84112
University of Utah Hospital & Clinics Salt Lake City Utah 84132
Dynacare Laboratories (Specimen processing for shipment) Seattle Washington 98122
Investigational Drug Service Pharmacy, Swedish Medical Center. Seattle Washington 98122
Seattle Rheumatology Associates Seattle Washington 98122
Swedish Medical Center Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01877668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2017 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01877668 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →